JSM 2013 Home
Online Program Home
My Program

Abstract Details

Activity Number: 343
Type: Topic Contributed
Date/Time: Tuesday, August 6, 2013 : 10:30 AM to 12:20 PM
Sponsor: International Chinese Statistical Association
Abstract - #309318
Title: Preclinical to Human Translation: Correctable Errors?
Author(s): Mandy Bergquist*+
Companies: GlaxoSmithKline
Keywords: translation ; drug discovery ; preclinical ; communication

In Phase 2 clinical trials, over 50% of new projects fail for lack of efficacy. The standard response is that preclinical models do not represent human disease adequately. While there are several challenges in translating preclinical efficacy to humans, statistical errors in the preclinical studies may make translation virtually impossible. A recent publication in Nature (Begley, CG and Ellis, LM (2012)) concluded that the lack of rigor around the generation and analysis of preclinical data today is similar to the situation in clinical research about 50 years ago. Reviewing the current state of design, analysis, and interpretation of preclinical pharmacology studies highlights the challenges as well as intriguing possibilities. The routine application of statistical concepts could dramatically improve translation, resulting in tremendous gains for drug research. The difficulty lies in getting from here to there - a task that likely requires more communication and influence than computational skill.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2013 program

2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.